Work

Thalidomide and celecoxib as potential modulators of irinotecan’s activity in cancer patients

Year: 2006

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-006-0249-y

Authors: Miguel Villalona-Calero, Larry Schaaf, Gary Phillips, Gregory Otterson, Kevin Panico, Wenrui Duan, Barbara Kleiber, Manisha Shah, Donn Young, Wan-Hong Wu, John Kuhn

Institutions: The Ohio State University Wexner Medical Center, The Ohio State University, The University of Texas at San Antonio Health Science Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2008684764

FWCI: 0.246

Cites: 36

Cited by: 10

Related to: 10